BR112013009407B8 - METHOD FOR MANUFACTURING NALTREXONE - Google Patents

METHOD FOR MANUFACTURING NALTREXONE

Info

Publication number
BR112013009407B8
BR112013009407B8 BR112013009407A BR112013009407A BR112013009407B8 BR 112013009407 B8 BR112013009407 B8 BR 112013009407B8 BR 112013009407 A BR112013009407 A BR 112013009407A BR 112013009407 A BR112013009407 A BR 112013009407A BR 112013009407 B8 BR112013009407 B8 BR 112013009407B8
Authority
BR
Brazil
Prior art keywords
naltrexone
manufacturing
dihydroxy
alpha
epoxy
Prior art date
Application number
BR112013009407A
Other languages
Portuguese (pt)
Other versions
BR112013009407B1 (en
BR112013009407A2 (en
Inventor
De Faveri Carla
Anton Martin Huber Florian
Stivanello Mariano
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Priority claimed from PCT/DK2011/000128 external-priority patent/WO2012059103A1/en
Publication of BR112013009407A2 publication Critical patent/BR112013009407A2/en
Publication of BR112013009407B1 publication Critical patent/BR112013009407B1/en
Publication of BR112013009407B8 publication Critical patent/BR112013009407B8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Abstract

MÉTODO PARA A FABRICAÇÃO DE NALTREXONA. A presente invenção refere-se a um processo melhorado para produzir naltrexona [17-(ciclopropilmetil)-4,5(Alfa)-epóxi-3,14-diidróxi-mofinan-6-ona] a partir de noroximorfona [4,5-(Alfa)-epóxi-3,14-diidróxi-morfinan-6-ona] pela alquilação com um haleto de ciclopropilmetila.METHOD FOR MANUFACTURING NALTREXONE. The present invention relates to an improved process for producing naltrexone [17-(cyclopropylmethyl)-4,5(Alpha)-epoxy-3,14-dihydroxy-mofinan-6-one] from noroxymorphone [4,5- (Alpha)-epoxy-3,14-dihydroxy-morphinan-6-one] by alkylation with a cyclopropylmethyl halide.

BR112013009407A 2010-11-05 2011-11-04 METHOD FOR MANUFACTURING NALTREXONE BR112013009407B8 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA201001007 2010-11-05
DKPA201001007 2010-11-05
DKPA201100396 2011-05-25
DKPA201100396 2011-05-25
PCT/DK2011/000128 WO2012059103A1 (en) 2010-11-05 2011-11-04 Method for the manufacturing of naltrexone

Publications (3)

Publication Number Publication Date
BR112013009407A2 BR112013009407A2 (en) 2016-07-19
BR112013009407B1 BR112013009407B1 (en) 2021-07-20
BR112013009407B8 true BR112013009407B8 (en) 2022-11-22

Family

ID=46552826

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013009407A BR112013009407B8 (en) 2010-11-05 2011-11-04 METHOD FOR MANUFACTURING NALTREXONE

Country Status (12)

Country Link
KR (1) KR101837795B1 (en)
CN (1) CN103237804B (en)
AR (1) AR087142A1 (en)
BR (1) BR112013009407B8 (en)
CL (1) CL2013001251A1 (en)
CO (1) CO6700868A2 (en)
IL (1) IL225790A (en)
JO (1) JO3209B1 (en)
PE (2) PE20140357A1 (en)
SG (1) SG189369A1 (en)
TW (1) TWI516491B (en)
ZA (1) ZA201303224B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005768A1 (en) * 1989-10-16 1991-05-02 The United States Of America, Represented By The Secretary, United States Department Of Commerce Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via n-nor intermediates
UA87884C2 (en) * 2004-12-03 2009-08-25 Мерк Энд Ко., Инк. Potassium salt of an hiv integrase inhibitor
FR2906252B1 (en) * 2006-09-21 2008-11-28 Sanofi Aventis Sa PROCESS FOR THE PREPARATION OF NALTREXONE N-AKLYL HALIDES
WO2008138383A1 (en) * 2007-05-16 2008-11-20 Cilag Ag Method for the production of n-methyl naltrexone bromide
WO2010039209A2 (en) * 2008-09-30 2010-04-08 Mallinckrodt Inc. Processes for the synthesis of tertiary amines

Also Published As

Publication number Publication date
ZA201303224B (en) 2014-07-30
TW201219396A (en) 2012-05-16
KR20130129928A (en) 2013-11-29
CO6700868A2 (en) 2013-06-28
BR112013009407B1 (en) 2021-07-20
CN103237804A (en) 2013-08-07
IL225790A0 (en) 2013-06-27
IL225790A (en) 2016-07-31
JO3209B1 (en) 2018-03-08
AR087142A1 (en) 2014-02-26
TWI516491B (en) 2016-01-11
PE20171309A1 (en) 2017-09-05
CN103237804B (en) 2016-06-08
BR112013009407A2 (en) 2016-07-19
SG189369A1 (en) 2013-05-31
KR101837795B1 (en) 2018-03-12
PE20140357A1 (en) 2014-03-29
CL2013001251A1 (en) 2013-08-30

Similar Documents

Publication Publication Date Title
BR112012029925A2 (en) granulated pumice as well as process for producing granulated pumice
NL1036038C (en) Multilayer preform obtained by electro-spinning, method for producing a preform as well as use thereof.
BR112014019909A8 (en) PROCESS FOR THE PRODUCTION OF COMPOUNDS USEFUL AS OREXIN-2 RECEPTOR ANTAGONISTS
IL229118A0 (en) Method for producing phenylacetamide compound
BR112013001966A2 (en) process for manufacturing an adhesive by extrusion
CY1118742T1 (en) METHOD FOR PREPARING NALTREXON
BRPI1013355A2 (en) process for the production of ethylene vinyl acetate copolymers by emulsion polymerization
BR112012000210A2 (en) process for the production of glutamic acid heterodimers.
BR112012020824A2 (en) process for producing coated molded bodies.
BR112012010210A2 (en) improved process for producing a thermofertilizer from potassium-containing minerals
EP2549837A4 (en) Method for producing organic electroluminescence element
EP2693839A4 (en) Organic led element, light-transmitting substrate, and method for producing light-transmitting substrate
BR112013013407A8 (en) process for producing one or more alcohols from gaseous substrate
EP2508797A4 (en) Method for producing a led lamp, led lamp obtained by said method, and radiator for said lamp
BR112013027976A2 (en) processes and intermediates in the preparation of morphine analogs by n-demethylation of n-oxides using cyclohydration reagents
BRPI0912113A2 (en) process for the manufacture of at least one ethylene derivative compound
PL2581398T3 (en) Method for producing low viscosity, water-emulsifiable allophanates with radiation curable groups
IT1397886B1 (en) PROCEDURE FOR THE PRODUCTION OF FUEL COMPONENTS FOR AUTOMOTIVE.
BR112012004902A2 (en) flexible coatings compounds with mineral preponderance
EP2287141A4 (en) Method for producing unsaturated organic compound
BRPI1010144A2 (en) method for producing an immunoglobulin or defined glycostructure immunoglobulin fragment
IL227592A0 (en) Method for producing 2,2-difluoroethylamine starting from 2,2-difluoro-1-chloroethane
BR112012029626A2 (en) process for preparing dithianone tetracarboxy dimides
IL207523A0 (en) Method for producing isothiocyanate compound having carboxyl group
BR112012000494A2 (en) process for substituted 3-amino-5-oxo-4,5-dihydro [1,2,4] triazines

Legal Events

Date Code Title Description
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/11/2011, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2637 DE 20/07/2021 QUANTO A QUALIFICACAO DO TITULAR.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.